Sherin Rouhani
7PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|May 25, 2024
Studying Outcomes after Steroid-Sparing Immunosuppressive Agent vs. Steroid-Only Treatment for Immune-Related Adverse Events in Non-Small-Cell Lung Cancer (NSCLC) and Melanoma: A Retrospective Case-Control Study.Sharjeel Syed, Jacobi Hines, Rachel Baccile
|Jan 05, 2023
STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer.Rohan R Katipally, Liam F Spurr, Stanley I Gutiontov
|Jan 03, 2023
Association Between Rheumatic Autoantibodies and Immune-Related Adverse Events.Kristen Mathias, Sherin Rouhani, Daniel Olson
|Oct 07, 2022
Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity.Priscilla S Briquez, Sherin J Rouhani, Jovian Yu
|Aug 17, 2022
Checkpoint Blockade-Induced Dermatitis and Colitis Are Dominated by Tissue-Resident Memory T Cells and Th1/Tc1 Cytokines.Robin Reschke, Jason W Shapiro, Jovian Yu
|Jun 22, 2022
Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies.Sherin Juliet Rouhani, Jovian Yu, Daniel Olson
Pageof 2
Frequent Collaborators
4 joint publications
Thomas F Gajewski
3 joint publications
Pankti Reid
3 joint publications
Jovian Yu
2 joint publications
Daniel Olson
1 joint publications
Garth W Strohbehn
1 joint publications
Brian L Heiss
1 joint publications
Jennifer Pisano
1 joint publications
Mary E Strek
1 joint publications
Mark J Ratain
1 joint publications
Robin Reschke
